Interferon beta 1b

DRUG2 trials

Sponsors

Insel Gruppe AG, University Hospital Bern, Novartis Pharmaceuticals

Conditions

Multiple Sclerosis

Phase 2

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b

CompletedNCT00942591

Insel Gruppe AG, University Hospital BernMultiple Sclerosis

Start: 2005-05-31End: 2009-05-31Updated: 2009-07-21

Phase 4

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

CompletedNCT01333501

Novartis PharmaceuticalsMultiple Sclerosis

Start: 2011-05-31End: 2015-09-30Updated: 2017-03-21

Related Papers

Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial

PLoS ONE2014-01-3026 citations

SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology.

2009-12-149 citations